Value of a Plan:  For the Healthcare Industry

National Perspectives Panel:Stephen B. CoulstonPresident & Managing PrincipalBroaddus Planning, Austin, TX

Governor’s Healthcare Economic Development SummitJackson Convention Complex, Jackson, MS

August 15, 2013

National Growth in Healthcare Industry

National Trends

Source: The Atlantic, 2012, Census, Pegasus 2013

Growth in population & healthcare spending –

28% of US population are baby boomers; healthcare spending per capita in US increased from $144 in 1960 to $4,400 in 2000.

Even with decline in population, healthcare occupational demand will increase – especially given the aging population.

The Innovation Economy

Innovation economic development is about the conversion of knowledge to a new venture – the commercialization of applied research. It is about building an ecosystem.

Innovation

We define innovation as bringing value to the Research Valley through facilitating emerging science and technology new ventures that lead to jobs, investment, and expanded research in a global market place.

Biocorridor

Case Study:  Research Valley Biocorridor

The Research ValleyCenter of the “Texas Triangle” (Bryan-College Station, TX)Home of Texas A&MAccess to Port of Houston and global distribution networkLow cost of doing business (labor, utility, tax and logistic expenses)Access to a motivated, highly-educated workforce

Texas A&M University

Research Valley Biocorridor

An international destination promoting research, education, and economic development: the innovation environment

An ecosystem to enhance collaboration among faculty, students, industry, government, and the community

The world’s first pronouncement and implementation of theOneHealth Plus™ concept

Recognition of Texas A&M, Blinn College and the Research Valley as pioneers

Planning Objectives

Desired OutcomesA plan, that through implementation, catalyzes substantial economic impact in the region facilitating increased research funding, workforce development, and high wage jobs creation at all levels for area residents and Texas A&M graduates

Projected DeliverablesCONCEPT LAND USE MASTER PLAN

Public and private ownership considerationsPRIORITY INFRASTRUCTURE PROJECTS 

Capital Plan with preliminary costingIMPLEMENTATION STRATEGY

Unified effortFunding

Partnership Approach

Critical stakeholders (government, institutions, business, community):Blinn CollegeBrazos CountyCity of BryanCity of College StationResearch Valley Partnership

Texas A&M University SystemTexas A&M UniversityTexas A&M Health Science CenterTexas A&M AgriLifeTexas Engineering Extension Service

Broad community support:State and local elected officials Institutional executive administrationsCommunity business leadersLocal economic development organizationsPlanning and zoning commissionsNeighbors and community at-largeLocal utilities and engineering departmentsState department of transportation

Hwy 47

R. Stotzer Blvd.

Extent of Planning Zone

3,500 acres

Hwy 47

R. Stotzer Blvd.

City of Bryan ETJ~200 Acres

City of College Station ETJ~200 Acres

City of College Station~650 Acres

City of Bryan~820Acres

TAM‐HSC~230 Acres

TAM‐AgriLife~700 Acres

USDA~70 Acres

TAMU~100 Acres

TAMU‐VetMed~390 Acres

Cemetery~60 Acres

Multiple Parties/Ownership

Multiple jurisdictions and property owners

Hwy 47

TAMAgriLife

TAMUVET MED PASTURE

PRE‐CLINICAL & OFFICE

TAMHEALTH SCIENCECENTER

MIXED‐USERESIDENTIAL

SENIOR HEALTH

MEMORIALCEMETERY

MIXED USE & MFG.

MFG.

CIVIC.

TOWN CENTER

TAMUVET MED CAMPUS

MIXEDUSE

MIXEDUSE

MIXED‐USE DRUG 

DISCOVERY & OFFICE

MIXED‐USE

MIXED USE & MFG.

CIVIC.

CIVIC.

CIVIC

Shared Vision: Concept Plan

Plan Framework

Shared Vision: Concept Plan

OneHealth Plus™ Research Valley Biocorridor Plan

Research Valley Biocorridor ‐ Investment

• Research - Texas A&M Institute for Genomic Medicine• Preclinical - Texas A&M Institute for Preclinical Studies• Clinical - Texas A&M Health Science Center• Manufacturing - National Center for Therapeutic Manufacturing

Over $412M Investment in Biomedical Sciences

Texas A&M Institute for Preclinical Studies (TIPS) $40,500,000

Texas A&M Institute for Genomic Medicine (TIGM)$13,000,000

National Center for Therapeutics Manufacturing (NCTM$45,500,000

Interdisciplinary Life Sciences Building (ILSB)$96,900,000

Texas A&M College of Veterinary Medicine and Biomedical Sciences (CVM)

Caliber Biotherapeutics (Project GreenVax)$60,000,000

Texas A&M Health Science Center Campus$56,900,000

The Research Valley Partnership (RVP)

Center of Innovation in Advanced Development & Mfg.

March 2013:The U.S. DHHS approves $91 million influenza-vaccine manufacturing facility to be run by the Texas A&M University System and GlaxoSmithKline, a global pharmaceutical company.

The system predicts that the project will generate $41 billion in expenditures and more than 6,800 jobs for the state over the next 25 years.

July 2012U.S. Department of Health and Human Services awards $285 million federal contract to develop the Center for Innovation in Advanced Development and Manufacturing, one of three new national centers focused on developing and manufacturing medicine and vaccines to respond to pandemic diseases and bioterror threats in Bryan-College Station, TX.

The Importance of a Plan

Why should we plan?Develop a shared vision and build awarenessIdentify priorities that recognize long term goals and near term needsChart a path to implementation that ensures sound investments

VALUE OF A PLAN